Management of diabetic macular edema in Japan: a review and expert opinion-Reference-Cited by-同舟云学术

Management of diabetic macular edema in Japan: a review and expert opinion

Published:2017-12-05 Issue:1 Volume:62 Page:1-23
ISSN:0021-5155
Container-title:Japanese Journal of Ophthalmology
language:en
Short-container-title:Jpn J Ophthalmol

Author:

Terasaki Hiroko,Ogura Yuichiro,Kitano Shigehiko,Sakamoto Taiji,Murata Toshinori,Hirakata Akito,Ishibashi Tatsuro

Funder

Novartis Pharma K.K.

Santen Pharmaceutical Co., Ltd

Bayer Health Care

Pfizer Japan Inc.

Wacamoto Co., Ltd

Bayer

Novartis

Alcon Japan

Santen

Senju

Kowa

Topcon

Sanwa Kagaku

Baush Lomb

Wakamoto

Janssen Pharma

Kissei Pharma

Alcon Pharma

HOYA

Novartis Pharma

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

http://link.springer.com/article/10.1007/s10384-017-0537-6/fulltext.html

Reference171 articles.

1. International Diabetes Federation. IDF diabetes atlas. 7th ed. 2015. http://www.diabetesatlas.org/component/attachments/?task=download&id=116 . Accessed 14 Mar 2017.

2. Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122:1375–94.

3. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36.

4. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–39.

5. Stewart MW. Anti-VEGF therapy for diabetic macular edema. Curr Diab Rep. 2014;14:510.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection;BMC Ophthalmology;2024-08-20

2. Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study;European Journal of Ophthalmology;2024-08-14

3. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial;Japanese Journal of Ophthalmology;2024-07-31

4. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-12

5. Characterization of the visually impaired patients with diabetes mellitus in Japan;Journal of Diabetes Investigation;2024-03-27